Clinical Trial Update: Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether vitamin D supplementation affects pathologic complete response rates in vitamin D-deficient patients with triple-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Triple Negative Breast Cancer, Vitamin D Deficiency | Phase 2 | Status: RECRUITING